Restore Vision Announces First-in-Human Clinical Interim Results for RV-001, a GPCR-Based Optogenetic Gene Therapy Written by PR Newswire Enable JavaScript and cookies to continueRead more http://www.prnasia.com/story/archive/4947853_CN47853_0